iCount: Cannabis as An Alternative to Substance and Drug Use Study!

Welcome to iCount: Cannabis as an Alternative to Substance and Drug Use study!

The first 150 participants will receive one entry to a lottery drawing for a $100 Visa gift card. The winner will be contacted through the email provided in the survey!

Medical cannabis has been shown in the general civilian and Veteran populations to play a role in improving quality of life and reducing the use of alcohol, opioids, in addition to other unwanted prescription, over-the-counter, and recreational drug use. Canadian clinical guidelines integrated low dose cannabis products containing THC as an adjunctive therapy, observing better pain control clinically with lower doses of opioids, improved pain related outcomes, and reduced opioid related harm.

The Cannabis Center of Excellence with support from Ayr Wellness announced today the launch of a new iCount research study: Cannabis as An Alternative to Substance and Drug Use for canna-curious or those who consume recreational or medical cannabis who are currently or have in the past used cannabis to reduce the use of: alcohol, tobacco, unwanted prescription medications, over the counter medications, opioids, or recreational drugs including: heroin, fentanyl, or other street drugs.

People who are “cannabis-curious”, those who do not consume cannabis but are interested in learning more about how cannabis is being used to reduce other substance use are also welcome to participate. Those interested can anonymously share their experiences through a 5-minute online survey and participants will be entered into a lottery to receive a gift card for participating.

The research study launched today, and cannabis consumers, patients, or the canna-curious can take the survey until Nov 31, 2023